Compare New York Times Co (NYT) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
New York Times Co vs Tenet Healthcare Corporation — how do they compare? New York Times Co trades at $75.8 (market cap $12.29B), while Tenet Healthcare Corporation trades at $196.03 (market cap $16.74B). The key difference: Tenet Healthcare Corporation is the larger of the two by market cap, and New York Times Co pays a 1.21% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| NYT | THC | |
|---|---|---|
Market Cap | $12.29B | $16.74B |
Sector | Media | Health |
52-Week High | $85.86 | $244.80 |
52-Week Low | $51.43 | $148.38 |
Enterprise Value | $11.68B | $26.99B |
Dividend Yield | 1.21% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
The New York Times Company (NYSE: NYT) trades at $74.69, down 1.63% on the day, with a bullish technical signal from moving averages and recent earnings beats. Revenue grew to $2.82 billion in 2025, with net income margin expanding to 12.17%. The stock is supported by strong cash flow from operations of $584 million and a consensus analyst price target of $78.00. Recent news includes the company's motion to quash subpoenas related to reporting on Air Force One, highlighting ongoing legal and press freedom challenges.
Outlook remains positive with consistent earnings growth and a defensive profile amid geopolitical tensions, but risks include regulatory pressures and competitive threats to digital subscriptions. The stock offers a dividend yield with the next payment scheduled for July 23, 2026. Institutional sentiment is mixed with a majority hold rating, suggesting cautious optimism for near-term appreciation toward the price target.
Tenet Healthcare (THC) trades at $194.38, down 0.27% on the day, with a bearish technical signal but strong fundamentals. The stock has beaten EPS estimates for three consecutive quarters, with a Q2 2026 report due July 24. Valuation metrics appear attractive with a P/E of 10.11 and P/S of 0.79. Revenue and net income are projected to grow in 2026, supported by expansion in outpatient care.
The outlook is positive given analyst consensus with 81% buy ratings and a $234.63 price target, implying 21% upside. Risks include potential pressure from lower patient days and high debt levels. Earnings growth and ambulatory care performance remain key catalysts for near-term momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About New York Times Co
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as nytimes and various smartphone applications. Circulation of The New York Times is the source of revenue for the company, followed by print and digital advertising and its paid digital-only subscription to The New York Times. The company has a daily print circulation of over 500,000 and 1,000,000 on Sundays. The source of growth for The New York Times is its digital subscription service, which has over 1,000,000 paid users.
Read more on NYT →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
